MDV Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MDV Pharma
Largest movements
- Receivables within one year +€90,041
up €90,041 (+3194.3%), from €2,819 to €92,860
of which Other amounts receivable: +€51,305
- Cash -€50,282
down €50,282 (-44.0%), from €114,374 to €64,092
mainly Receivables within one year (-€90,041) and Contributions, distributions and other (-€68,000)
- Debts after one year -€57,362
down €57,362 (-8.2%), from €703,754 to €646,392
- Other debts +€46,972
up €46,972 (+8.5%), from €554,442 to €601,413
- Profit (loss) carried forward +€26,429
up €26,429 (+11.1%), from €237,774 to €264,203
- Financial income -€60,000
down €60,000 (-40.0%), from €150,000 to €90,000
- Gross operating margin -€11,163
down €11,163 (-30.9%), from €36,165 to €25,002
- Other operating charges +€5,146
up €5,146 (+661.9%), from €777 to €5,923
- Depreciation +€2,655
up €2,655 (+49.8%), from €5,330 to €7,986
- Taxes -€1,369
down €1,369, from €1,332 to -€37
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,562,532 | €1,587,281 | +€24,749 | +1.6% |
| Formation expenses | 20 | €156 | €13 | -€143 | -91.8% |
| Fixed assets | 21/28 | €1,445,183 | €1,430,317 | -€14,866 | -1.0% |
| Tangible fixed assets | 22/27 | €44,545 | €29,679 | -€14,866 | -33.4% |
| Furniture and vehicles | 24 | €44,545 | €29,679 | -€14,866 | -33.4% |
| Financial fixed assets | 28 | €1,400,638 | €1,400,638 | = | 0.0% |
| Current assets | 29/58 | €117,193 | €156,951 | +€39,759 | +33.9% |
| Amounts receivable within one year | 40/41 | €2,819 | €92,860 | +€90,041 | +3194.3% |
| Trade receivables | 40 | - | €38,736 | +€38,736 | |
| Other amounts receivable | 41 | €2,819 | €54,124 | +€51,305 | +1820.1% |
| Cash at bank and in hand | 54/58 | €114,374 | €64,092 | -€50,282 | -44.0% |
| Total equity and liabilities | 10/49 | €1,562,532 | €1,587,281 | +€24,749 | +1.6% |
| Equity | 10/15 | €240,274 | €266,703 | +€26,429 | +11.0% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Outside capital | 11 | €2,500 | €2,500 | = | 0.0% |
| Other | 1109/19 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €237,774 | €264,203 | +€26,429 | +11.1% |
| Amounts payable | 17/49 | €1,322,258 | €1,320,578 | -€1,680 | -0.1% |
| Amounts payable after more than one year | 17 | €703,754 | €646,392 | -€57,362 | -8.2% |
| Financial debts | 170/4 | €703,754 | €646,392 | -€57,362 | -8.2% |
| Amounts payable within one year | 42/48 | €618,504 | €666,686 | +€48,182 | +7.8% |
| Current portion of amounts payable after more than one year | 42 | €58,973 | €57,362 | -€1,611 | -2.7% |
| Trade debts | 44 | €3,090 | €3,448 | +€358 | +11.6% |
| Suppliers | 440/4 | €3,090 | €3,448 | +€358 | +11.6% |
| Advances received on contracts in progress | 46 | - | €2,500 | +€2,500 | |
| Taxes, remuneration and social security | 45 | €2,000 | €1,963 | -€37 | -1.9% |
| Taxes | 450/3 | €2,000 | €1,963 | -€37 | -1.9% |
| Other amounts payable | 47/48 | €554,442 | €601,413 | +€46,972 | +8.5% |
| Accrued charges and deferred income | 492/3 | - | €7,500 | +€7,500 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,330 | €7,986 | +€2,655 | +49.8% |
| Other operating charges | 640/8 | €777 | €5,923 | +€5,146 | +661.9% |
| Gross operating margin | 9900 | €36,165 | €25,002 | -€11,163 | -30.9% |
| Operating profit (loss) | 9901 | €30,057 | €11,093 | -€18,964 | -63.1% |
| Financial income | 75/76B | €150,000 | €90,000 | -€60,000 | -40.0% |
| Recurring financial income | 75 | €150,000 | €90,000 | -€60,000 | -40.0% |
| Financial charges | 65/66B | €7,236 | €6,701 | -€535 | -7.4% |
| Recurring financial charges | 65 | €7,236 | €6,701 | -€535 | -7.4% |
| Profit (loss) for the period before taxes | 9903 | €172,821 | €94,392 | -€78,429 | -45.4% |
| Income taxes | 67/77 | €1,332 | -€37 | -€1,369 | |
| Profit (loss) for the period | 9904 | €171,489 | €94,429 | -€77,060 | -44.9% |
| Profit (loss) for the period to be appropriated | 9905 | €171,489 | €94,429 | -€77,060 | -44.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.